The Patent Finder

Terms ending in 2030

Sandoz AG

Every in-force patent on Sandoz AG's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,475,838Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
In force
 · High confidence
Sandoz AGIn forceHigh confidence
US 8,513,224Crystalline Form C of Tigecycline Dihydrochloride and Methods for Its Preparation
In force
 · High confidence
Sandoz AGIn forceHigh confidence
US 8,691,534Preparation of Romidepsin
In force
 · High confidence
Celgene CorporationIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Sandoz AG.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited